NuCana price target lowered to $20 from $150 at Truist

Truist lowered the firm’s price target on NuCana to $20 from $150 and keeps a Buy rating on the shares. The firm is updating its model following the company’s recent program developments, assigning no credit to its NUC-3373 and a 25% probability of success to NUC-7738, the analyst tells investors in a research note, adding that the new price target more accurately reflects changes in the company’s lead program.